Log in to save to my catalogue

Engineered adeno-associated virus 3 vector with reduced reactivity to serum antibodies

Engineered adeno-associated virus 3 vector with reduced reactivity to serum antibodies

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_21dbdb3102a64787821dc94a450f9501

Engineered adeno-associated virus 3 vector with reduced reactivity to serum antibodies

About this item

Full title

Engineered adeno-associated virus 3 vector with reduced reactivity to serum antibodies

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2021-04, Vol.11 (1), p.9322-9322, Article 9322

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

The natural serotypes of adeno-associated virus (AAV) or their variants, such as AAV8 and AAV5, are commonly used as vectors in the clinical programs for liver-targeted gene therapy. While AAV8 vectors are not highly efficient at targeting primary human hepatocytes, AAV3 vectors have recently demonstrated remarkable efficiency at targeting both hum...

Alternative Titles

Full title

Engineered adeno-associated virus 3 vector with reduced reactivity to serum antibodies

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_21dbdb3102a64787821dc94a450f9501

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_21dbdb3102a64787821dc94a450f9501

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/s41598-021-88614-9

How to access this item